(Atlanta, GA) --The Board of Directors of the American Partnership for Eosinophilic Disorders (APFED) has announced the election of a new board officer, James D ...

AAAAI represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and trea ...

International consensus surrounding what subsets of eosinophilic gastrointestinal d ...

In December 2021, APFED reported that the U.S. Food and Drug Administration (FDA) denied the TAK-721 New Drug Application, indicating the drug – a budesonide ...